---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-106359"
form_type: "8-K"
ticker: "KYNB"
cik: "0000921299"
company_name: "KYNTRA BIO, INC."
filed_at: "2024-09-13T23:59:59+00:00"
generated_at: "2026-05-31T05:06:47.291338+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# FibroGen directors Blaug, Cravatt, Lema resign effective Sept 30; committees reassigned

## Summary
- Suzanne Blaug, Benjamin Cravatt, and Gerald Lema resign from the Board effective September 30, 2024.
- Resignations are not due to any disagreement with the Company or its management.
- Audit Committee now comprises Jeffrey L. Edwards (Chair), Maykin Ho, and James A. Schoeneck.
- Compensation Committee: James A. Schoeneck (Chair) and Aoife Brennan; Nominating Committee: James A. Schoeneck (Chair) and Jeffrey L. Edwards.

## SEC filing metadata
- accession: 0000950170-24-106359
- form_type: 8-K
- ticker: KYNB
- cik: 0000921299
- company_name: KYNTRA BIO, INC.
- filed_at: 2024-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/0000950170-24-106359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/fgen-20240912.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-106359
- JSON: https://secwatch.observer/filing/0000950170-24-106359.json
- Plain text: https://secwatch.observer/filing/0000950170-24-106359.txt

## Key facts
- Executive change
  Suzanne Blaug resigned as Director at KYNTRA BIO, INC..
  - Action: resigned
  - Role: Director
  source text: On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/0000950170-24-106359-index.htm
- Executive change
  Gerald Lema resigned as Director at KYNTRA BIO, INC..
  - Action: resigned
  - Role: Director
  source text: On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/0000950170-24-106359-index.htm
- Executive change
  Benjamin Cravatt resigned as Director at KYNTRA BIO, INC..
  - Action: resigned
  - Role: Director
  source text: On September 12, 2024, Suzanne Blaug, Benjamin Cravatt, and Gerald Lema each provided to the Board of Directors (the “Board”) notification of their resignations from the Board of FibroGen, Inc. (the “Company”), effective September 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921299/000095017024106359/0000950170-24-106359-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.